136 related articles for article (PubMed ID: 23886196)
1. Potential therapeutic efficacy of curcumin in liver cancer.
Dai XZ; Yin HT; Sun LF; Hu X; Zhou C; Zhou Y; Zhang W; Huang XE; Li XC
Asian Pac J Cancer Prev; 2013; 14(6):3855-9. PubMed ID: 23886196
[TBL] [Abstract][Full Text] [Related]
2. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
Zhao J; Chen X; Lin W; Wu G; Zhuang Q; Zhong X; Hong Z; Peng J
Int J Oncol; 2013 Mar; 42(3):971-8. PubMed ID: 23338043
[TBL] [Abstract][Full Text] [Related]
3. Synergistic efficacy of curcumin and anti-programmed cell death-1 in hepatocellular carcinoma.
Guo L; Li H; Fan T; Ma Y; Wang L
Life Sci; 2021 Aug; 279():119359. PubMed ID: 33753114
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
Wang Y; Dong L; Li J; Luo M; Shang B
Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
[TBL] [Abstract][Full Text] [Related]
5. Noscapine inhibits human hepatocellular carcinoma growth through inducing apoptosis in vitro and in vivo.
Xu G; Niu Z; Dong J; Zhao Y; Zhang Y; Li X
Neoplasma; 2016; 63(5):726-33. PubMed ID: 27468876
[TBL] [Abstract][Full Text] [Related]
6. Novel carbocyclic curcumin analog CUR3d modulates genes involved in multiple apoptosis pathways in human hepatocellular carcinoma cells.
Bhullar KS; Jha A; Rupasinghe HP
Chem Biol Interact; 2015 Dec; 242():107-22. PubMed ID: 26409325
[TBL] [Abstract][Full Text] [Related]
7. Curcumin induces apoptosis involving bax/bcl-2 in human hepatoma SMMC-7721 cells.
Yu J; Zhou X; He X; Dai M; Zhang Q
Asian Pac J Cancer Prev; 2011; 12(8):1925-9. PubMed ID: 22292626
[TBL] [Abstract][Full Text] [Related]
8. Glucose-regulated protein 78 (GRP78) mediated the efficacy to curcumin treatment on hepatocellular carcinoma.
Chang YJ; Tai CJ; Kuo LJ; Wei PL; Liang HH; Liu TZ; Wang W; Tai CJ; Ho YS; Wu CH; Huang MT
Ann Surg Oncol; 2011 Aug; 18(8):2395-403. PubMed ID: 21347788
[TBL] [Abstract][Full Text] [Related]
9. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells.
Abdallah FM; Helmy MW; Katary MA; Ghoneim AI
Naunyn Schmiedebergs Arch Pharmacol; 2018 Dec; 391(12):1399-1410. PubMed ID: 30155693
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives.
Shao JW; Dai YC; Xue JP; Wang JC; Lin FP; Guo YH
Eur J Med Chem; 2011 Jul; 46(7):2652-61. PubMed ID: 21514015
[TBL] [Abstract][Full Text] [Related]
11. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
Abdel-Hamid NI; El-Azab MF; Moustafa YM
Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
[TBL] [Abstract][Full Text] [Related]
12. Autophagy and apoptosis in hepatocellular carcinoma induced by EF25-(GSH)2: a novel curcumin analog.
Zhou T; Ye L; Bai Y; Sun A; Cox B; Liu D; Li Y; Liotta D; Snyder JP; Fu H; Huang B
PLoS One; 2014; 9(9):e107876. PubMed ID: 25268357
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of cucurbitacin B in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells.
Sun Y; Zhang J; Zhou J; Huang Z; Hu H; Qiao M; Zhao X; Chen D
Eur J Pharmacol; 2015 Dec; 768():28-40. PubMed ID: 26452516
[TBL] [Abstract][Full Text] [Related]
15. Artemisia capillaris extract AC68 induces apoptosis of hepatocellular carcinoma by blocking the PI3K/AKT pathway.
Yan H; Jung KH; Kim J; Rumman M; Oh MS; Hong SS
Biomed Pharmacother; 2018 Feb; 98():134-141. PubMed ID: 29253760
[TBL] [Abstract][Full Text] [Related]
16. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
Lu XL; Zeng J; Chen YL; He PM; Wen MX; Ren MD; Hu YN; Lu GF; He SΧ
Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
[TBL] [Abstract][Full Text] [Related]
17. Alpinia oxyphylla oil induces apoptosis of hepatocellular carcinoma cells via PI3K/Akt pathway in vitro and in vivo.
Hui F; Qin X; Zhang Q; Li R; Liu M; Ren T; Zhao M; Zhao Q
Biomed Pharmacother; 2019 Jan; 109():2365-2374. PubMed ID: 30551496
[TBL] [Abstract][Full Text] [Related]
18. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
Zhang G; Zeng X; Zhang R; Liu J; Zhang W; Zhao Y; Zhang X; Wu Z; Tan Y; Wu Y; Du B
Phytomedicine; 2016 Nov; 23(12):1329-1336. PubMed ID: 27765352
[TBL] [Abstract][Full Text] [Related]
19. V8, a newly synthetic flavonoid, induces apoptosis through ROS-mediated ER stress pathway in hepatocellular carcinoma.
Zhang Y; Zhao L; Li X; Wang Y; Yao J; Wang H; Li F; Li Z; Guo Q
Arch Toxicol; 2014 Jan; 88(1):97-107. PubMed ID: 23835921
[TBL] [Abstract][Full Text] [Related]
20. Dryocrassin ABBA Induces Apoptosis in Human Hepatocellular Carcinoma HepG2 Cells Through a Caspase-Dependent Mitochondrial Pathway.
Jin Z; Wang WF; Huang JP; Wang HM; Ju HX; Chang Y
Asian Pac J Cancer Prev; 2016; 17(4):1823-8. PubMed ID: 27221859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
